首页> 外文会议>Conference of the American College of Veterinary Internal Medicine >MANAGING CANINE MAST CELL TUMORS: AN UPDATE ON DIAGNOSIS AND TREATMENT
【24h】

MANAGING CANINE MAST CELL TUMORS: AN UPDATE ON DIAGNOSIS AND TREATMENT

机译:管理犬肥大细胞肿瘤:关于诊断和治疗的更新

获取原文

摘要

Mast cell tumors are the most commonly occurring skin tumor in dogs, comprising 16 to 21% of all skin tumors. [1] Breeds that are at increased risk for mast cell tumor (MCT) development include Boxers, pugs, Boston terriers, English bulldogs, Golden retriever, Labrador retrievers, Staffordshire terriers and beagles; male and female dogs have a similar risk of developing MCT.[1] Mast cells are a white blood cell that normally function as important mediators of immediate (type I) hypersensitivity. These cells arise from the bone marrow and normally reside in many tissues of the body, including the skin, liver, spleen, and gastrointestinal tract. Mast cells have numerous granules that contain bioactive substances such as heparin, histamine, proteases and tumor necrosis factor-a (TNF-a) which are important for development of an immune/allergic response after detection of an antigen. [2] While important in health, these bioactive substances can cause complications for dogs with MCT; these complicationsare reviewed at the end of the material presented here.
机译:肥大细胞肿瘤是犬中最常见的皮肤肿瘤,包含16至21%的所有皮肤肿瘤。 [1]肥大细胞肿瘤风险增加(MCT)开发的繁殖包括拳击手,哈巴狗,波士顿犬,英国斗牛犬,金毛猎犬,拉布拉多猎犬,斯塔福德郡梗犬和猎犬;男女狗具有类似的发展MCT的风险。[1]肥大细胞是一种白细胞,通常用作立即(I型)超敏反应的重要介质。这些细胞出现来自骨髓,通常存在于身体的许多组织中,包括皮肤,肝脏,脾和胃肠道。肥大细胞具有许多颗粒,其含有生物活性物质,例如肝素,组胺,蛋白酶和肿瘤坏死因子-A(TNF-A),这对于检测抗原检测后的免疫/过敏反应是重要的。 [2]虽然在健康中重要,但这些生物活性物质可能导致狗的并发症与MCT;这些并发帐在此处提供的材料结束时审查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号